Showing 1721-1730 of 7702 results for "".
Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReEvolution in Dermatology/Industry Partnerships
https://practicaldermatology.com/topics/practice-management/evolution-in-dermatologyindustry-partnerships/23295/The COVID-19 crisis is changing the dermatology industry. What does it mean?Meet the Virtualist
https://practicaldermatology.com/topics/practice-management/meet-the-virtualist/23290/What will teledermatology look like in the post COVID-19 era?The Road Map to Success: When Does it Make Sense to Have a Dermatology PA?
https://practicaldermatology.com/topics/practice-management/the-road-map-to-success-when-does-it-make-sense-to-have-a-dermatology-pa/23235/Adding a new provider can increase access and boost the bottom line. But how do you choose?2019 Medical Aesthetic Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/2019-medical-aesthetic-trends/19696/What were the hot medical aesthetic trends of 2019 and what’s in the pipeline for 2020? Joel L. Cohen, MD weighs in.Atopic Dermatitis: Rethinking the “Typical” Patient
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-rethinking-the-typical-patient/19666/It's possible to make generalities about the experience of atopic dermatitis, but it's increasingly clear that there is no "typical" patient. Zelma Chiesa Fuxench, MD discusses the latest findings on the signs and symptoms of AD and the populations affected.The State of Pediatric Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-pediatric-dermatology/23060/The subspecialty needs to expand its workforce to continue to meet critical patient need.Fundamentals of Growing Your Services and Practice with Women
https://practicaldermatology.com/topics/practice-management/fundamentals-of-growing-your-services-andpractice-with-women/23052/Despite hype about men, women are the future of aesthetics. Here are seven principles to engage potential female patients, gain trust, and convert them to loyal customers.The Importance of Early Intervention for Port-Wine Stains in Infancy
https://practicaldermatology.com/topics/pediatric/the-importance-of-early-intervention-forport-wine-stains-in-infancy/23029/Early intervention can have long-term benefits.What ’s the Best Approach to AK Therapies? Ask an Expert
https://practicaldermatology.com/topics/skin-cancer-photoprotection/what-s-the-best-approach-to-ak-therapies-ask-an-expert/19622/Rather than consider AK a specific disease, Vishal A. Patel, MD, FAAD says it can be viewed as a marker of disease, which culminates in SCC. In this edition of Ask an Expert with Adam Friedman, MD, about his philosophy of treatment, including long-term maintenance.